Thrombotic Microangiopathy with Skin Localization Secondary to Cytarabine-Daunorubicin Association: Report of a Case

The thrombotic microangiopathy is a syndrome characterized by the combination of mechanical hemolytic anemia, peripheral thrombocytopenia, and organ failure of variable severity. In addition to the idiopathic form, several cases are identified as secondary to pregnancy, infections, disease systems,...

Full description

Saved in:
Bibliographic Details
Main Authors: S. Regragui, S. Amelal, S. Astati, M. Zine, N. Alami Drideb, A. Al Bouzidi, N. Messaoudi, M. Benkirane, K. Doghmi, M. Mikdame
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2012/806476
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850224485726158848
author S. Regragui
S. Amelal
S. Astati
M. Zine
N. Alami Drideb
A. Al Bouzidi
N. Messaoudi
M. Benkirane
K. Doghmi
M. Mikdame
author_facet S. Regragui
S. Amelal
S. Astati
M. Zine
N. Alami Drideb
A. Al Bouzidi
N. Messaoudi
M. Benkirane
K. Doghmi
M. Mikdame
author_sort S. Regragui
collection DOAJ
description The thrombotic microangiopathy is a syndrome characterized by the combination of mechanical hemolytic anemia, peripheral thrombocytopenia, and organ failure of variable severity. In addition to the idiopathic form, several cases are identified as secondary to pregnancy, infections, disease systems, organ transplants, and cancer. Other forms are secondary to drugs including antimitotics. We report the case of a patient followed for acute myelogenous leukemia. She received induction chemotherapy combining daunorubicin and cytarabine, complicated by thrombotic thrombocytopenic purpura.
format Article
id doaj-art-4f737f10a3ef412f8d7c18b8db9304b2
institution OA Journals
issn 2090-6560
2090-6579
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Case Reports in Hematology
spelling doaj-art-4f737f10a3ef412f8d7c18b8db9304b22025-08-20T02:05:36ZengWileyCase Reports in Hematology2090-65602090-65792012-01-01201210.1155/2012/806476806476Thrombotic Microangiopathy with Skin Localization Secondary to Cytarabine-Daunorubicin Association: Report of a CaseS. Regragui0S. Amelal1S. Astati2M. Zine3N. Alami Drideb4A. Al Bouzidi5N. Messaoudi6M. Benkirane7K. Doghmi8M. Mikdame9Department of Clinical Hematology, Military Hospital Mohammed V, Rabat, MoroccoDepartment of Clinical Hematology, Military Hospital Mohammed V, Rabat, MoroccoDepartment of Clinical Hematology, Military Hospital Mohammed V, Rabat, MoroccoDepartment of Clinical Hematology, Military Hospital Mohammed V, Rabat, MoroccoDepartment of Clinical Hematology, Military Hospital Mohammed V, Rabat, MoroccoDepartment of Pathology, Military Hospital Mohammed V, Rabat, MoroccoDepartment of Biological Hematology, Military Hospital Mohammed V, Rabat, MoroccoBlood Transfusion Centre, Military Hospital Mohammed V, Rabat, MoroccoDepartment of Clinical Hematology, Military Hospital Mohammed V, Rabat, MoroccoDepartment of Clinical Hematology, Military Hospital Mohammed V, Rabat, MoroccoThe thrombotic microangiopathy is a syndrome characterized by the combination of mechanical hemolytic anemia, peripheral thrombocytopenia, and organ failure of variable severity. In addition to the idiopathic form, several cases are identified as secondary to pregnancy, infections, disease systems, organ transplants, and cancer. Other forms are secondary to drugs including antimitotics. We report the case of a patient followed for acute myelogenous leukemia. She received induction chemotherapy combining daunorubicin and cytarabine, complicated by thrombotic thrombocytopenic purpura.http://dx.doi.org/10.1155/2012/806476
spellingShingle S. Regragui
S. Amelal
S. Astati
M. Zine
N. Alami Drideb
A. Al Bouzidi
N. Messaoudi
M. Benkirane
K. Doghmi
M. Mikdame
Thrombotic Microangiopathy with Skin Localization Secondary to Cytarabine-Daunorubicin Association: Report of a Case
Case Reports in Hematology
title Thrombotic Microangiopathy with Skin Localization Secondary to Cytarabine-Daunorubicin Association: Report of a Case
title_full Thrombotic Microangiopathy with Skin Localization Secondary to Cytarabine-Daunorubicin Association: Report of a Case
title_fullStr Thrombotic Microangiopathy with Skin Localization Secondary to Cytarabine-Daunorubicin Association: Report of a Case
title_full_unstemmed Thrombotic Microangiopathy with Skin Localization Secondary to Cytarabine-Daunorubicin Association: Report of a Case
title_short Thrombotic Microangiopathy with Skin Localization Secondary to Cytarabine-Daunorubicin Association: Report of a Case
title_sort thrombotic microangiopathy with skin localization secondary to cytarabine daunorubicin association report of a case
url http://dx.doi.org/10.1155/2012/806476
work_keys_str_mv AT sregragui thromboticmicroangiopathywithskinlocalizationsecondarytocytarabinedaunorubicinassociationreportofacase
AT samelal thromboticmicroangiopathywithskinlocalizationsecondarytocytarabinedaunorubicinassociationreportofacase
AT sastati thromboticmicroangiopathywithskinlocalizationsecondarytocytarabinedaunorubicinassociationreportofacase
AT mzine thromboticmicroangiopathywithskinlocalizationsecondarytocytarabinedaunorubicinassociationreportofacase
AT nalamidrideb thromboticmicroangiopathywithskinlocalizationsecondarytocytarabinedaunorubicinassociationreportofacase
AT aalbouzidi thromboticmicroangiopathywithskinlocalizationsecondarytocytarabinedaunorubicinassociationreportofacase
AT nmessaoudi thromboticmicroangiopathywithskinlocalizationsecondarytocytarabinedaunorubicinassociationreportofacase
AT mbenkirane thromboticmicroangiopathywithskinlocalizationsecondarytocytarabinedaunorubicinassociationreportofacase
AT kdoghmi thromboticmicroangiopathywithskinlocalizationsecondarytocytarabinedaunorubicinassociationreportofacase
AT mmikdame thromboticmicroangiopathywithskinlocalizationsecondarytocytarabinedaunorubicinassociationreportofacase